From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
- 1 April 2018
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 465 (C) , 113-121
Abstract
No abstract availableKeywords
Funding Information
- Muscular Dystrophy Association (479363)
- Telethon-Italy and Provincia Autonoma di Trento-Italy (TCP12013)
- Association Française contre les Myopathies (18722)
- Pump Priming Funding from the University of Oxford (AV5690-SD850)
- Wellcome Trust (205162/Z/16/Z)
This publication has 106 references indexed in Scilit:
- Clearance of the mutant androgen receptor in motoneuronal models of spinal and bulbar muscular atrophyNeurobiology of Aging, 2013
- Androgen Receptor Gene Expression in Prostate Cancer Is Directly Suppressed by the Androgen Receptor Through Recruitment of Lysine-Specific Demethylase 1Cancer Cell, 2011
- Efficacy and safety of dutasteride in patients with spinal and bulbar muscular atrophy: a randomised placebo-controlled trialThe Lancet Neurology, 2011
- An Interdomain Interaction of the Androgen Receptor Is Required for Its Aggregation and Toxicity in Spinal and Bulbar Muscular AtrophyJournal of Biological Chemistry, 2010
- Native Functions of the Androgen Receptor Are Essential to Pathogenesis in a Drosophila Model of Spinobulbar Muscular AtrophyNeuron, 2010
- Standard and modified statistical mune evaluations in spinal‐bulbar muscular atrophyMuscle & Nerve, 2009
- Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular AtrophyNeuron, 2009
- Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregatesNature Cell Biology, 2009
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004
- Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the α1A-voltage-dependent calcium channelNature Genetics, 1997